noom semaglutide price launches full-page ad in Wall Street Journal advocating for policy changes regarding compounded GLP-1s Noom Med Plans & Pricing

Our Health and Wellness Institute is coming up with a digital health coaching platform to help people track their metrics both with physical activity and nutrition

Pictured: Woman grasping her stomach in pain/iStock, Doucefleur The use of glucagon-like peptide 1 (GLP-1) agonists for weight loss, such as Novo Nordisks Ozempic and Wegovy, is associated with the risk of gastrointestinal adverse events, according to a study published Thursday in the medical journal JAMA

in: Zi Z, Liu X, editors

Wu H, Liu J, Yin Y, Zhang D, Xia P, Zhu G

Research shows that postmenopausal women have significantly higher fasting insulin levels and reduced glucose tolerance compared to premenopausal women of similar age and body composition

Gopal Grandhige, a board-certified general surgeon (American Board of Surgery) who specializes in aesthetic surgery, takes a comprehensive approach to each patients care, factoring in medical history, current medications, body composition, and individual goals